BMI Calculator — Do You Qualify for GLP-1 Weight Loss?
Enter your height and weight to calculate your Body Mass Index (BMI) and see if you may qualify for physician-supervised GLP-1 treatment.
Understanding BMI Categories
| BMI Range | Category | GLP-1 Eligibility |
|---|---|---|
| Below 18.5 | Underweight | Not eligible |
| 18.5 – 24.9 | Normal weight | Not typically eligible |
| 25.0 – 26.9 | Overweight | Not typically eligible without comorbidities |
| 27.0 – 29.9 | Overweight | Eligible with comorbidity (diabetes, hypertension, etc.) |
| 30.0 and above | Obese | Eligible |
Limitations of BMI
BMI is a useful screening tool but has important limitations. It doesn't distinguish between muscle and fat — a muscular athlete may have a "high" BMI while being metabolically healthy. It doesn't account for fat distribution — abdominal fat carries more health risk than fat elsewhere. And it doesn't consider age, sex, or ethnicity differences in body composition.
That's why physician evaluation matters. At New Hope Weight Loss, Dr. Sharma considers your complete health picture — not just a number on a chart — when determining treatment eligibility.
Frequently Asked Questions
What BMI do I need for semaglutide or tirzepatide?
FDA guidelines specify BMI ≥ 30 (obesity) or BMI ≥ 27 with at least one weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea.
What counts as a "weight-related condition"?
Type 2 diabetes, pre-diabetes, hypertension (high blood pressure), dyslipidemia (high cholesterol/triglycerides), obstructive sleep apnea, cardiovascular disease, and osteoarthritis are all recognized weight-related conditions that may qualify you for GLP-1 treatment at BMI 27–29.9.
Is BMI the only factor in eligibility?
No. Your physician also evaluates contraindications (conditions that prevent treatment), current medications, and your overall health profile. Our medical intake questionnaire screens for all relevant factors.
Disclaimer: This BMI calculator is for informational purposes only and is not a medical diagnostic tool. BMI has known limitations and should not be the sole basis for medical decisions. Consult a physician for personalized health assessment.
New Hope Weight Loss | 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly. Compounded medications are not FDA-approved products.